Recursion Pharmaceuticals Inc - Class A

RXRX | $7.6 3.4% 3.35% 3.4M

(0.0% 1d) (-27.8% 1m) (40.7% 1y) (0.0% 2d) (0.0% 3d) (1.7% 7d) (-1.67% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 1,726,289,848
https://www.recursionpharma.com
Sec Filling | Patents | n/a employees

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to its mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what Recursion believes is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate its programs. biotechnology company scaling more like a technology company.

drug discovery machine learning

add to watch list Paper trade email alert is off

Press-releases

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -9.52% | O: -9.4% H: 2.1% C: -0.53%
JNJ | News | $149.12 0.82% 0.3% 7.2M

Health Technology

| 0.65% | O: -2.09% H: 0.0% C: 0.0%
commercial

Recursion to Participate in Upcoming Investor Conference
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -23.54% | O: -9.86% H: 0.45% C: -2.12%
conference

Recursion Publishes Annual Environmental, Social and Governance Report
Published: 2024-03-26 (Crawled : 12:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -27.83% | O: 0.76% H: 2.64% C: -2.73%
report

Recursion Announces Plans to Open New Office in London
Published: 2024-03-11 (Crawled : 08:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -32.08% | O: 1.43% H: 1.76% C: -8.63%

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
Published: 2024-03-01 (Crawled : 20:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| Email alert Add to watchlist
day rare disease

Recursion to Participate in Upcoming Investor Conferences
Published: 2024-03-01 (Crawled : 13:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -43.54% | O: -0.15% H: 1.41% C: -4.69%
MS | News | $92.09 1.58% 0.07% 4.9M

Finance

| 7.03% | O: 0.21% H: 0.66% C: 0.3%

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 21:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -51.03% | O: -10.81% H: 2.29% C: -6.52%
business year financial results

Recursion to Host Public L(earnings) Call on February 27
Published: 2024-02-20 (Crawled : 13:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -42.21% | O: -0.76% H: 0.23% C: -3.52%

Altitude Lab Startups Raise Over $120M in Capital
Published: 2024-01-24 (Crawled : 14:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -28.57% | O: 1.88% H: 1.38% C: -4.43%
altitude

Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 16:00) - globenewswire.com
RXRX | $7.6 3.4% 3.35% 3.4M

Professional, Scientific, and T...

| -36.3% | O: 1.17% H: 5.39% C: 4.47%
drug conference software

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001628280-24-015103	4	2024-04-05	2024-04-04	Sell	C	25000	486000
0001628280-24-015103	4	2024-04-05	2024-04-03	Sell	C	25000	67875
0001628280-24-015103	4	2024-04-05	2024-04-03	Sell	S	25000	0
0001628280-24-015103	4	2024-04-05	2024-04-03	Buy	C	25000	25000
0001628280-24-015103	4	2024-04-05	2024-04-04	Sell	S	40000	938524
0001628280-24-015103	4	2024-04-05	2024-04-03	Sell	S	40000	978524
0001628280-24-015103	4	2024-04-05	2024-04-03	Sell	G	25000	1018524